Family facts
IDVParent PIID36F79720D0180
Also listed as36F797-20-D-0180
Agency241-Network Contract Office 01 (36C241)
Awarding office241-Network Contract Office 01 (36C241)
Awarding agencyDepartment of Veterans Affairs (VA)
Period endJun 30, 2027
IDV obligated$38.6M
Child awards31
Places of performance
StatesAZ, CA, CT, FL, IL, MO, NJ, PA
Distinctive task orders
1236C24826F0082 — PLUVICTO
Novartis Pharmaceuticals Corp. · $4.7M · PoP Aug 31, 2026
36C25726N0205 — LU177 - PLUVICTO/LUTATHERA
Novartis Pharmaceuticals Corp. · $4.2M · PoP Feb 6, 2027
36C25725N0190 — LUTATHERA & PLUVICTO
Novartis Pharmaceuticals Corp. · $4.1M · PoP Feb 6, 2026
36C26126F0007 — PLUVICTO DRUG
Novartis Pharmaceuticals Corp. · $4.0M · PoP Sep 30, 2026
36C26226N0112 — PLUVICTO AND LUTATHERA
Novartis Pharmaceuticals Corp. · $3.9M · PoP Oct 31, 2026
36C25026N0310 — RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA
Novartis Pharmaceuticals Corp. · $2.4M · PoP Dec 31, 2026
36C24426F0063 — RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS
Novartis Pharmaceuticals Corp. · $2.0M · PoP Dec 31, 2026
36C26126F0017 — PLUVICTO FY26
Novartis Pharmaceuticals Corp. · $1.6M · PoP Sep 30, 2026
36C26126F0168 — PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML
Novartis Pharmaceuticals Corp. · $1.0M · PoP Sep 30, 2026
36C26226F0048 — PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
Novartis Pharmaceuticals Corp. · $1.0M · PoP Jan 1, 2027
36C25225F0191 — DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO.
Novartis Pharmaceuticals Corp. · $1.0M · PoP Aug 31, 2026
36C26226F0314 — PLUVICTO DELIVERY ORDER
Novartis Pharmaceuticals Corp. · $823K · PoP Dec 31, 2026
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly